Amneal Pharmaceuticals (NasdaqGS:AMRX) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAnastasios Konidaris - EVP and CFOAnthony DiMeo - Head of Investor RelationsChintu Patel - Co-Founder and Co-CEOChirag Patel - Co-Founder and Co-CEOChris Schott - Managing DirectorJoe Renda - SVP and Chief Commercial OfficerConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystLes Sulewski - AnalystMatt Dellatorre - VP and Equity AnalystOperatorThank you all for ...

Amneal Pharmaceuticals (NasdaqGS:AMRX) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Speaker8Thank you all for your patience. The conference call titled Amneal Pharmaceuticals Fourth Quarter and Full Year 2025 Earnings Call will begin shortly. During the presentation, you'll have the opportunity to ask a question by pressing Star followed by the number one on your telephone keypads. Again, please stand by and we will begin in a few minutes. Good morning. Welcome to the Amneal Pharmaceuticals Fourth Qu ...